In saying that and the quarterlies do all show $0 receipts for last year with the exception of January 13's extension however the half yearly report last month says $700K has been invoiced revenue for January / March 2014 ? So is this the expansion payment highlighted in July that so far hasn't been seen 9 months later ?
"The Company’s cash position after completion of the entitlement issue on 8th January 2013 was $6.2 million, with $0.7 million of invoiced revenue to be received January/ March 2014 and approximately $1.8 million from the R&D tax offset in September 2014. Expenditure is presently running at the rate of $0.45 million per month which annualises to $5.4 million.
going intracellular, page-79
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $559.9M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 11.5¢ | $308.5K | 2.533M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 358350 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 371822 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| PYC (ASX) Chart |